EC approves mogamulizumab for MF, SSNovember 28, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Canada expands approval for antihemophilic factorNovember 28, 2018ThrombosisPharmacyBleeding Disorders
Pegfilgrastim biosimilar approved by ECNovember 28, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
EC approves pegfilgrastim biosimilarNovember 27, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Quick FDA approval for brentuximab vedotin in PTCLNovember 16, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
FDA approves generic drugs for APLNovember 16, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
FDA and EC approve pegfilgrastim biosimilarNovember 4, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Health Canada approves pralatrexate for rel/ref PTCLNovember 2, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma